3/18/11 Contest Update
Not a fun week. But if the “Supermoon” Cassandras are correct we ain’t seen nuthin’ yet.
news.yahoo.com
At Friday’s close, the Nasdaq Biotech Index was up .84% YTD (vs. up 2.56% YTD a week ago) and the Contest median was down -1.93% YTD (vs. down -.2.58% YTD a week ago). The Nasdaq Composite Index was down -.35% YTD (vs. up 2.36% YTD a week ago).
MCBIO’s portfolio (up 18.64% YTD) was steady during a very rocky week and remains in first place. RKRW’s portfolio (up 15.09% YTD) actually finished the week with a gain and held on to second place. ROCKY’s portfolio (up 13.11% YTD) moved into to the No. 3 slot.
At Friday's close, 14 of the 38 Contest portfolios were in the black with 11 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None.
Have a safe Supermoon weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
3/18/11
Rank Name Profit/Loss
1 MCBIO 18,641
2 RKRW 15,093
3 ROCKY 13,113
4 GENE 8,692
5 RRGE 8,213
6 IJF 7,141
7 IMAN 6,354
8 STEVEL 4,151
9 CRAZYP 2,529
10 FIB 1,606
Week's Top 5 Gainers
Symbol 3/11 3/18 % change
ARIA 5.71 6.40 12.08%
GENT 9.15 10.09 10.27%
SSRX 15.40 16.70 8.44%
AVEO 13.91 15.02 7.98%
RDEA 26.31 28.35 7.75%
Week's Top 5 Losers
Symbol 3/11 3/18 % change
AOB 2.29 1.69 -26.20%
MNOV 4.75 3.59 -24.42%
TKMR 4.87 3.71 -23.82%
BNVI 0.73 0.57 -21.92%
SKBI 6.95 5.52 -20.58% |
